Floatz logo

25 assets in Acute Myeloid Leukemia With 11q23 Abnormalities

Therapeutic assets addressing Acute Myeloid Leukemia With 11q23 Abnormalities, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Daunomycin
Acute Myeloid Leukemia With 11q23 Abnormalities
National Cancer Institute (NCI)P3BBB (77)
Etoposide
Acute Myeloid Leukemia With 11q23 Abnormalities
M.D. Anderson Cancer CenterP3BBB (77)
Cytarabine
Acute Myeloid Leukemia With 11q23 Abnormalities
Alice MimsP3BBB (76)
Cyclophosphamide
Acute Myeloid Leukemia With 11q23 Abnormalities
M.D. Anderson Cancer CenterP3BBB (74)
Fludarabine
Acute Myeloid Leukemia With 11q23 Abnormalities
M.D. Anderson Cancer CenterP3BBB (73)
Nivestim
Acute Myeloid Leukemia With 11q23 Abnormalities
M.D. Anderson Cancer CenterP3BBB (72)
Azacitidine
Acute Myeloid Leukemia With 11q23 Abnormalities
Northwestern UniversityP2BB (71)
Busulfanum
Acute Myeloid Leukemia With 11q23 Abnormalities
M.D. Anderson Cancer CenterP3BB (70)
Cediranib
Acute Myeloid Leukemia With 11q23 Abnormalities
Alice MimsP3BB (70)
Clofarabine
Acute Myeloid Leukemia With 11q23 Abnormalities
M.D. Anderson Cancer CenterP3BB (70)
Romidepsin
Acute Myeloid Leukemia With 11q23 Abnormalities
M.D. Anderson Cancer CenterP3BB (70)
Decitabine
Acute Myeloid Leukemia With 11q23 Abnormalities
Sumithira VasuP3BB (69)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit
Acute Myeloid Leukemia With 11q23 Abnormalities
M.D. Anderson Cancer CenterP2BB (66)
Gemtuzumab Ozogamicin
Acute Myeloid Leukemia With 11q23 Abnormalities
Wake Forest University Health SciencesP2BB (64)
Melphalan
Acute Myeloid Leukemia With 11q23 Abnormalities
M.D. Anderson Cancer CenterP2B (57)
Ziftomenib
Acute Myeloid Leukemia With 11q23 Abnormalities
Massachusetts General HospitalP1/2CCC (54)
NK-92
Acute Myeloid Leukemia With 11q23 Abnormalities
M.D. Anderson Cancer CenterP2CCC (53)
Rituximab
Acute Myeloid Leukemia With 11q23 Abnormalities
M.D. Anderson Cancer CenterP2CCC (53)
BN104
Acute Myeloid Leukemia With 11q23 Abnormalities
Institut de Recherches Internationales Servier (I.R.I.S.)P1/2CCC (48)
Itraconazole
Acute Myeloid Leukemia With 11q23 Abnormalities
Kura Oncology, Inc.P1/2CCC (48)
Midazolam
Acute Myeloid Leukemia With 11q23 Abnormalities
Kura Oncology, Inc.P1/2CCC (48)
Nintedanib
Acute Myeloid Leukemia With 11q23 Abnormalities
Northwestern UniversityP1CC (43)